Clinical Trials Sponsored by Patara Pharma

Total 9073 results

Patara Pharma

Completed

Treatment of Uremic Pruritus With PA101B

Uremic Pruritus

United States
Patara Pharma

Completed

Treatment of Indolent Systemic Mastocytosis With PA101

Systemic Mastocytosis | Mastocytosis | Indolent Systemic Mastocytosis

France, Germany, Spain, Italy, Netherlands
Patara Pharma

Completed

Treatment of Refractory Chronic Cough With PA101

Refractory Chronic Cough

Netherlands, United Kingdom
Petra Pharma

Unknown

A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors

Breast Cancer | Head and Neck Cancer | Lung Cancer | Endometrial Cancer | Colo-rectal Cancer
Centro Regional para el Estudio de las Enfermedades...
MERZ PHARMA

Completed

Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy.

Hepatic Encephalopathy

Mexico
R-Pharm
Covance; Cromos Pharma LLC

Withdrawn

Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).

COVID-19
Para Federal University

Completed

The Use of Low Level Laser Therapy for Wound Healing in Leprosy Patients

Leprosy

Brazil
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056

Rheumatoid Arthritis

United States, Belgium, United Kingdom
Universidade Federal do Para

Not yet recruiting

Pregabalin Gel in Reducing Post-operative Tooth Sensitivity Surgery Caused by Bleaching With 35% Hydrogen Peroxide

Tooth Bleaching | Sensitivity, Tooth

Brazil
Universidade Federal do Para

Completed

Propolis in Reducing Dentin Hypersensitivity

Dentin Sensitivity

Brazil
Universidade Federal do Para

Completed

Whitening Efficacy and Tooth Sensitivity of Different Concentrations of Hydrogen Peroxide Photoactivated With Violet or Blue LEDs

Color | Bleaching Sensitivity

Brazil
Universidade Federal do Para

Completed

The Effect of an Experimental Gel Based on Acmella Oleracea Extract in Reducing Post-bleaching Tooth Sensitivity

Pain | Tooth Bleaching | Dentin Desensitizing Agents

Brazil
Universidade Federal do Para

Completed

CPP-ACPF and Laser's Effect on Dentin Hypersensitivity

Dentin Sensitivity

Brazil
Universidade Federal do Para

Completed

Effect of Nano-hydroxyapatite and LASER on Dentin Hypersensitivity

Dentin Sensitivity

Brazil
Universidade Federal do Para

Completed

Effect of Low-level Laser Therapy on Post-bleaching Sensitivity and Color Change

Dentin Sensitivity | Tooth Bleaching | Clinical Trial | Low-level Laser Therapy

Brazil
Universidade Federal do Para

Completed

Evaluation of the Effect of Fluoride and Laser Application on the Prevention of Sensitivity in Bleached Teeth

Dentin Sensitivity
AJU Pharm Co., Ltd.
OM Pharma SA

Recruiting

The Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Chronic Prostatitis With Chronic Pelvic Pain Syndrome | Chronic Prostatitis | Chronic Pelvic Pain Syndrome

Korea, Republic of
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

The Long-term Safety and Efficacy of CDP6038 (Olokizumab) With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Japan, Korea, Republic of, Taiwan
Universidade Federal do Para

Completed

Association of Two Desensitizing Protocols to Control Dentinal Hypersensitivity in Non-carious Lesions

Dental Hypersensitivity

Brazil
Universidade Federal do Para

Completed

Analysis of the Influence of Desensitizing Treatments on the Pulp Inflammatory Response in Bleached Teeth

Pulp Inflammation

Brazil
Yuria-Pharm
Pharmaxi LLC

Completed

Epidemiological Study of the COVID-2019 in Participating Organizations.

Covid19

Ukraine
Universidade Federal do Para

Recruiting

The Association of CPP-ACPF Associated With LASER in the Treatment of Tooth Sensitivity After at Home Bleaching

Sensitivity, Tooth

Brazil
Universidade Federal do Para

Recruiting

Clinical Performance of Different Adhesive Strategies With a Universal System in Sclerosed Dentin in NCCL: A Double-blind Randomized Clinical Trial.

Sclerotic Dentine | Non Carious Cervical Lesion

Brazil
Universidade Federal do Para

Completed

The Effect of an Experimental Gel Based on Copaiba Oil Resin in Reducing Post-bleaching Tooth Sensitivity

Tooth Bleaching Pain

Brazil
Universidade Federal do Para

Completed

Effect of Glutaraldehyde-based Desensitizer in the Control of Tooth Sensitivity and Tooth Color Post- Whitening

Dentin Sensitivity

Brazil
Universidade Federal do Para

Completed

Influence of Polishing After Bleaching on Color Change and Enamel Morphology

Tooth Discoloration | Tooth Sensitivity | Morphologic Change

Brazil
Universidade Federal do Para

Completed

Clinical Performance of Adhesive Systems Containing HEMA and 10-MDP in Non Carious Cervical Lesions

Non Carious Cervical Lesion

Brazil
Universidade Federal do Para

Completed

Effect of 1.5% Potassium Oxalate on the Control of Tooth Sensitivity and Color Change After Home Bleaching

Dentin Sensitivity

Brazil
Universidade Federal do Para

Completed

Effect of Glutaraldehyde on Dentin Hypersensitivity After Non-surgical Periodontal Treatment

Dentin Sensitivity

Brazil
Fundación Pública Andaluza para la gestión de la...
Gebro Pharma GmbH

Unknown

Time-based Register and Analysis of COPD Endpoints (TRACE)

COPD

Spain
Fundación Pública Andaluza para la Investigación...
Adventia Pharma

Completed

Efficacy of Two ONS in Patients at Nutritional Risk With Type 2 Diabetes Mellitus (DIACARE)

Malnutrition | Type 2 Diabetes

Spain
Atara Biotherapeutics

Recruiting

A Study to Evaluate Tabelecleucel in Participants With Epstein-barr Virus-associated Diseases

Lymphoproliferative Disorders | Leiomyosarcoma | Stem Cell Transplant Complications | Solid Organ Transplant Complications | Epstein-Barr Virus (EBV)-Associated Diseases | EBV+ Post-transplant Lymphoproliferative Disease (EBV+ PTLD) | Allogeneic Hematopoietic Cell Transplant | EBV+ Sarcomas | EBV+ Lymphoproliferative... and other conditions

United States, Austria, Belgium, France, Italy, Spain, United Kingdom
Atara Biotherapeutics

Recruiting

Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy (ALLELE)

Lymphoproliferative Disorders | Stem Cell Transplant Complications | Solid Organ Transplant Complications | Allogeneic Hematopoietic Cell Transplant | Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)

United States, Austria, Australia, Belgium, Canada, France, Italy, Spain, United Kingdom
Atara Biotherapeutics

No longer available

Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies

Lymphoproliferative Disorders | Stem Cell Transplant Complications | Epstein-Barr Virus (EBV) Infections | EBV+ Associated Lymphoma | EBV+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD) | Epstein-Barr Viremia | Lymphoma, AIDS-related | Epstein-Barr Virus-associated Lymphoproliferative... and other conditions
Atara Biotherapeutics

Recruiting

A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

High-grade B-cell Lymphoma | MCL | Diffuse Large B-cell Lymphoma (DLBCL) | Relapsed/Refractory B-cell Non-Hodgkin Lymphoma | DLBCL/High-grade B-cell Lymphoma With MYC and BCL2 Rearrangements | Anaplastic Lymphoma Kinase-Positive Large B-Cell Lymphoma | LBCL With IRF4 Rearrangement | High-grade B-cell... and other conditions

United States
Atara Biotherapeutics

Terminated

Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis (EMBOLD)

Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple Sclerosis

United States, Australia, Canada
Atara Biotherapeutics

No longer available

Expanded Access Protocol of ATA230 (Third-Party Donor-Derived CMV-CTLs) for the Treatment of CMV Viremia or Disease

CMV Viremia | CMV Disease
PT Sydna Farma
PT Pharma Metric Labs

Completed

Bioequivalence Study of Cyproterone Acetate and Ethinyl Estradiol in Healthy Female Volunteers

Drug Use

Indonesia
Monash University
Caring Pharmacy; Bionime Corporation; Tigas Pharma

Active, not recruiting

Prevention and Treatment of Diabetes in Adults

PreDiabetes

Malaysia
Asociación para el Progreso de la Oncología en...
Roche Farma, S.A

Completed

Characteristics of Disseminated Her2+ Breast Cancer Patients Treated With Trastuzumab That Have Reached Complete, Partial Remission or Stabilization of Disease During More Than 3 Years (LongHer)

HER-2 Positive Breast Cancer

Spain
Fundación Iniciativa para las Neurociencias (FINCE)

Not yet recruiting

Phenotyping and Identification of Biological Markers in STXBP1 Encephalopathy (FIMBEX)

STXBP1 Encephalopathy With Epilepsy

Spain
Fundacion para la Salud Materno Infantil

Completed

Placental Transfusion and Cord Clamping

Placental Transfusion

Argentina
Fundacion para la Salud Materno Infantil

Terminated

Position at Birth,Placental Transfusion Volume and Cord Clamping

Delay Cord Clamping | Placental Trasfusion

Argentina
Fundacion para la Salud Materno Infantil

Terminated

Delayed Cord Clamping and Use of Oxytocin

Placental Transfusion

Argentina
UCB Biopharma S.P.R.L.
Pharm Research Associates (UK) Ltd.

Completed

Study to Look at How Effective Briviact is as add-on Treatment for Patients With Epilepsy With Partial Onset Seizures (BASE)

Epilepsy With POS With or Without Secondary Generalization

Denmark, Germany, Hungary, Ireland, Italy, Netherlands, Norway, Spain, United Kingdom
UCB Pharma SA

Completed

Open-label Long-term Study of Adjunctive Brivaracetam in Pediatric Subjects With Epilepsy

Epilepsy

United States, Belgium, Czechia, France, Germany, Hungary, Ireland, Italy, Mexico, Poland, Spain, United Kingdom
UCB Pharma SA

Completed

Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam

Epilepsy, Partial

Canada, United States
Vifor Pharma, Inc.

Terminated

Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia (EMERALD)

Hyperkalemia

United States, Bulgaria, Canada, Georgia, Germany, Poland, Ukraine
UCB Pharma SA

Completed

Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Epilepsy

Belgium, Finland, France, Germany, Hungary, India, Italy, Netherlands, Poland, Spain, Switzerland, United Kingdom
UCB Pharma SA

Completed

Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy

Generalized Epilepsy

Clinical Trials Sponsored by Patara Pharma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations